PRECIPIO, INC. (PRPO) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 7.57%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 7.57% | Share-based compensation / revenue. Period ending 2026-06-30. $2.10M ÷ $27.69M × 100 ≈ 7.57% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 27.69M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.10M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -1.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $27.69M | $2.10M | $-1.55M | (m) | (m) | 7.57% | (m) | (m) |
| 2026-03-31 | (m) | $26.30M | $1.78M | $-1.77M | (m) | (m) | 6.77% | (m) | (m) |
| 2025-12-31 | $1.60M | $24.25M | $1.21M | $-1.20M | (m) | 6.60% | 4.99% | (m) | (m) |
| 2025-09-30 | (m) | $22.74M | $1.54M | $-2.08M | (m) | (m) | 6.78% | (m) | (m) |
| 2025-06-30 | (m) | $21.13M | $1.71M | $-2.62M | (m) | (m) | 8.08% | (m) | (m) |
| 2025-03-31 | (m) | $20.01M | $1.56M | $-3.00M | (m) | (m) | 7.78% | (m) | (m) |
| 2024-12-31 | $1.30M | $18.58M | $1.49M | $-4.22M | (m) | 7.00% | 8.03% | (m) | (m) |
| 2024-09-30 | (m) | $17.64M | $1.44M | $-4.73M | (m) | (m) | 8.19% | (m) | (m) |
| 2024-06-30 | (m) | $16.93M | $1.41M | $-5.58M | (m) | (m) | 8.34% | (m) | (m) |
| 2024-03-31 | (m) | $16.06M | $1.47M | $-6.67M | (m) | (m) | 9.12% | (m) | (m) |
| 2023-12-31 | $1.70M | $15.41M | $1.56M | $-7.62M | (m) | 11.03% | 10.11% | (m) | (m) |
| 2023-09-30 | (m) | $13.60M | $1.56M | $-9.09M | (m) | (m) | 11.50% | (m) | (m) |
| 2023-06-30 | (m) | $11.32M | $1.92M | $-10.87M | (m) | (m) | 16.96% | (m) | (m) |
| 2023-03-31 | (m) | $10.12M | $2.02M | $-11.01M | (m) | (m) | 19.95% | (m) | (m) |
| 2022-12-31 | $1.70M | $9.82M | $3.80M | $-12.80M | (m) | 17.31% | 38.71% | (m) | (m) |
| 2022-09-30 | (m) | $9.47M | $3.97M | $-13.38M | (m) | (m) | 41.96% | (m) | (m) |
| 2022-06-30 | (m) | $9.31M | $3.76M | $-12.59M | (m) | (m) | 40.39% | (m) | (m) |
| 2022-03-31 | (m) | $9.11M | $3.67M | $-12.29M | (m) | (m) | 40.32% | (m) | (m) |
| 2021-12-31 | $1.30M | $8.70M | $1.88M | $-9.61M | (m) | 14.95% | 21.61% | (m) | (m) |
| 2021-09-30 | (m) | $8.75M | $1.47M | $-8.96M | (m) | (m) | 16.82% | (m) | (m) |
| 2021-06-30 | (m) | $8.66M | $1.17M | $-8.95M | (m) | (m) | 13.56% | (m) | (m) |
| 2021-03-31 | (m) | $8.06M | $972.00K | $-9.08M | (m) | (m) | 12.06% | (m) | (m) |
| 2020-12-31 | $1.20M | $7.43M | $703.00K | $-9.15M | (m) | 16.15% | 9.46% | (m) | (m) |
| 2020-09-30 | (m) | $6.11M | $754.00K | $-11.17M | (m) | (m) | 12.34% | (m) | (m) |
| 2020-06-30 | (m) | $5.11M | $690.00K | $-11.10M | (m) | (m) | 13.51% | (m) | (m) |
| 2020-03-31 | (m) | $4.66M | $680.00K | $-11.14M | (m) | (m) | 14.59% | (m) | (m) |
| 2019-12-31 | $1.20M | $4.09M | $668.00K | $-10.99M | (m) | 29.30% | 16.31% | (m) | (m) |
| 2019-09-30 | (m) | $4.03M | $642.00K | $-11.88M | (m) | (m) | 15.92% | (m) | (m) |
| 2019-06-30 | (m) | $3.81M | $616.00K | $-13.63M | (m) | (m) | 16.17% | (m) | (m) |
| 2019-03-31 | (m) | $3.57M | $603.00K | $-13.52M | (m) | (m) | 16.90% | (m) | (m) |
| 2018-12-31 | $1.10M | $3.45M | $529.00K | $-13.91M | (m) | 31.90% | 15.34% | (m) | (m) |
| 2018-09-30 | (m) | $3.12M | $358.00K | $-19.23M | (m) | (m) | 11.46% | (m) | (m) |
| 2018-06-30 | (m) | $2.74M | $246.00K | $-18.74M | (m) | (m) | 8.97% | (m) | (m) |
| 2018-03-31 | (m) | (m) | $155.00K | $-17.36M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $500.00K | $1.72M | $49.00K | $-15.51M | (m) | 29.02% | 2.84% | (m) | (m) |
| 2017-09-30 | (m) | (m) | $76.00K | $-11.97M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $68.00K | $-8.70M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.29M | $1.98M | $-82.00K | $-7.13M | (m) | 64.98% | -4.14% | (m) | (m) |
| 2016-12-31 | $1.42M | $1.56M | $52.00K | $-7.82M | (m) | 91.33% | 3.34% | (m) | (m) |
| 2016-09-30 | $1.54M | $1.33M | $233.00K | $-8.31M | (m) | 116.18% | 17.53% | (m) | (m) |
| 2016-06-30 | $1.61M | $1.20M | $408.00K | $-8.94M | (m) | 133.61% | 33.94% | (m) | (m) |
| 2016-03-31 | $1.67M | $1.14M | $607.00K | $-9.47M | (m) | 146.80% | 53.29% | (m) | (m) |
| 2015-12-31 | $1.85M | $1.65M | $611.00K | $-9.20M | (m) | 112.10% | 36.96% | (m) | (m) |
| 2015-09-30 | $2.43M | $29.16M | $431.00K | $-19.06M | (m) | 8.33% | 1.48% | (m) | (m) |
| 2015-06-30 | $2.51M | $27.62M | $624.00K | $-15.25M | (m) | 9.09% | 2.26% | (m) | (m) |
| 2015-03-31 | $2.72M | $27.34M | $722.00K | $-16.43M | (m) | 9.94% | 2.64% | (m) | (m) |
| 2014-12-31 | $2.90M | $27.08M | $939.00K | $-17.32M | (m) | 10.70% | 3.47% | (m) | (m) |
| 2014-09-30 | $3.08M | $25.61M | $1.29M | $-15.11M | (m) | 12.01% | 5.04% | (m) | (m) |
| 2014-06-30 | $3.06M | $25.88M | $937.00K | $-16.51M | (m) | 11.84% | 3.62% | (m) | (m) |
| 2014-03-31 | $3.19M | $26.42M | $629.00K | $-15.48M | (m) | 12.09% | 2.38% | (m) | (m) |
| 2013-12-31 | $3.21M | $27.54M | $462.00K | $-15.76M | (m) | 11.66% | 1.68% | (m) | (m) |
| 2013-09-30 | $2.93M | $28.62M | $343.00K | $-15.42M | (m) | 10.23% | 1.20% | (m) | (m) |
| 2013-06-30 | $2.97M | $29.86M | $422.00K | $-12.44M | (m) | 9.93% | 1.41% | (m) | (m) |
| 2013-03-31 | $2.71M | $31.65M | $622.00K | $-10.88M | (m) | 8.55% | 1.97% | (m) | (m) |
| 2012-12-31 | $2.49M | $31.48M | $731.00K | $-9.50M | (m) | 7.91% | 2.32% | (m) | (m) |
| 2012-09-30 | $2.44M | $32.76M | $832.00K | $-6.40M | (m) | 7.44% | 2.54% | (m) | (m) |
| 2012-06-30 | $2.29M | $33.12M | $716.00K | $-4.41M | (m) | 6.90% | 2.16% | (m) | (m) |
| 2012-03-31 | $2.21M | $31.70M | $1.27M | $-4.66M | (m) | 6.97% | 4.02% | (m) | (m) |
| 2011-12-31 | $2.22M | $31.97M | $1.01M | $-2.97M | (m) | 6.94% | 3.16% | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $2.31M | $20.05M | $-14.00K | $-3.61M | (m) | 11.50% | -0.07% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $3.18M | $22.02M | $202.00K | $-1.90M | (m) | 14.45% | 0.92% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |